HENT1 AND DCK EXPRESSION PREDICT BENEFIT FROM GEMCITABINE AFTER CURATIVE-INTENT RESECTION IN PANCREATIC ADENOCARCINOMA

被引：0
|
作者：
Marechal, Raphael [1 ]
Bachet, Jean-Baptiste [2 ]
Mackey, John R. [3 ]
Demetter, Pieter [1 ]
Graham, Kathryn [3 ]
Couvelard, Anne [4 ]
Svrcek, Magali [5 ]
Bardier-Dupas, Armelle [2 ]
Hammel, Pascal [4 ]
Sauvanet, Alain [4 ]
Louvet, Christophe [5 ]
Paye, Francois [5 ]
Rougier, Philippe [6 ]
Hannoun, Laurent [2 ]
Andre, Thierry [2 ]
Cass, Carol E. [3 ]
Salmon, Isabelle [1 ]
Emile, Jean-Francois [7 ]
Van Laethem, Jean-Luc [1 ]
机构：
[1] Free Univ Brussels, Hop Erasme, B-1070 Brussels, Belgium
[2] Hop La Pitie Salpetriere, Paris, France
[3] Univ Alberta, Cross Canc Inst, Edmonton, AB T6G 2M7, Canada
[4] Hop Beaujon, Paris, France
[5] Hop St Antoine, F-75571 Paris, France
[6] Hop Europeen Georges Pompidou, Paris, France
[7] Hop Ambroise Pare, Paris, France
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：v12 / v12
页数：1
相关论文
共 50 条
  • [1] Prediction of gemcitabine benefit after curative-intent resection of pancreatic adenocarcinoma using HENT1 and dCK protein expression.
    Marechal, R.
    Bachet, J.
    Mackey, J. R.
    Demetter, P.
    Graham, K.
    Couvelard, A.
    Svrcek, M.
    Bardier, A.
    Hammel, P.
    Sauvanet, A.
    Louvet, C.
    Paye, F.
    Rougier, P.
    Hannoun, L.
    Andre, T.
    Dumontet, C. M.
    Cass, C. E.
    Salmon, I.
    Emile, J.
    Van Laethem, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Do hENT1 and RRM1 predict the clinical benefit of gemcitabine in pancreatic cancer?
    Jordheim, Lars Petter
    Dumontet, Charles
    BIOMARKERS IN MEDICINE, 2013, 7 (04) : 663 - 671
  • [3] The association of epithelial expression of hENT1 and survival from adjuvant gemcitabine in pancreatic ductal adenocarcinoma (PDAC).
    Renouf, Daniel John
    Karasinska, Joanna
    Kalloger, Steve
    Samimi, Setareh
    Peixoto, Renata
    O'Connor, Kate
    Schaeffer, David
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] The association of epithelial expression of hENT1 and survival from adjuvant gemcitabine in pancreatic ductal adenocarcinoma (PDAC)
    Renouf, Daniel John
    Karasinska, Joanna
    Kalloger, Steve
    Peixoto, Renata D'Alpino
    O'Connor, Kate
    Schaeffer, David
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [5] Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer
    Elebro, Jacob
    Ben Dror, Liv
    Heby, Margareta
    Nodin, Bjorn
    Jirstrom, Karin
    Eberhard, Jakob
    ACTA ONCOLOGICA, 2016, 55 (03) : 286 - 296
  • [6] hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma
    Perera, Sheron
    Jang, Gun Ho
    Wang, Yifan
    Kelly, Deirdre
    Allen, Michael
    Zhang, Amy
    Denroche, Robert E.
    Dodd, Anna
    Ramotar, Stephanie
    Hutchinson, Shawn
    Tehfe, Mustapha
    Ramjeesingh, Ravi
    Biagi, James
    Lam, Bernard
    Wilson, Julie
    Fischer, Sandra E.
    Zogopoulos, George
    Notta, Faiyaz
    Gallinger, Steven
    Grant, Robert C.
    Knox, Jennifer J.
    O'Kane, Grainne M.
    CLINICAL CANCER RESEARCH, 2022, 28 (23) : 5115 - 5120
  • [7] hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
    Aughton, Karen
    Elander, Nils O.
    Evans, Anthony
    Jackson, Richard
    Campbell, Fiona
    Costello, Eithne
    Halloran, Christopher M.
    Mackey, John R.
    Scarfe, Andrew G.
    Valle, Juan W.
    Carter, Ross
    Cunningham, David
    Tebbutt, Niall C.
    Goldstein, David
    Shannon, Jennifer
    Glimelius, Bengt
    Hackert, Thilo
    Charnley, Richard M.
    Anthoney, Alan
    Lerch, Markus M.
    Mayerle, Julia
    Palmer, Daniel H.
    Buechler, Markus W.
    Ghaneh, Paula
    Neoptolemos, John P.
    Greenhalf, William
    CANCERS, 2021, 13 (22)
  • [8] hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review
    Stina Nordh
    Daniel Ansari
    Roland Andersson
    World Journal of Gastroenterology, 2014, (26) : 8482 - 8490
  • [9] The hENT1 Immunohistochemistry Diagnostic Test is Predictive of Gemcitabine Outcome in Pancreatic Ductal Adenocarcinoma
    Raponi, Mitch
    Isaacson, Jeff
    Hahn, Hejin
    Bartosiewicz, Mike
    Magnusson, Andrea
    Lin, Kevin
    Rolfe, Lindsey
    Allen, Andrew
    Picozzi, Vincent
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S84 - S85
  • [10] THE HENT1 IMMUNOHISTOCHEMISTRY DIAGNOSTIC TEST IS PREDICTIVE OF GEMCITABINE OUTCOME IN PANCREATIC DUCTAL ADENOCARCINOMA
    Raponi, M.
    Isaacson, J.
    Hahn, H.
    Bartosiewicz, M.
    Magnusson, A.
    Lin, K.
    Rolfe, L.
    Allen, A.
    Picozzi, V.
    ANNALS OF ONCOLOGY, 2012, 23 : 236 - 236
12345